Organon (OGN) Cash & Current Investments (2020 - 2025)
Organon (OGN) has 6 years of Cash & Current Investments data on record, last reported at $574.0 million in Q4 2025.
- For Q4 2025, Cash & Current Investments fell 18.47% year-over-year to $574.0 million; the TTM value through Dec 2025 reached $574.0 million, down 18.47%, while the annual FY2025 figure was $574.0 million, 18.47% down from the prior year.
- Cash & Current Investments reached $574.0 million in Q4 2025 per OGN's latest filing, down from $672.0 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $1.0 billion in Q3 2021 and bottomed at $141.0 million in Q1 2021.
- Average Cash & Current Investments over 5 years is $604.9 million, with a median of $635.5 million recorded in 2025.
- Peak YoY movement for Cash & Current Investments: soared 6041.67% in 2021, then tumbled 50.5% in 2022.
- A 5-year view of Cash & Current Investments shows it stood at $737.0 million in 2021, then decreased by 4.21% to $706.0 million in 2022, then decreased by 0.57% to $702.0 million in 2023, then increased by 0.28% to $704.0 million in 2024, then dropped by 18.47% to $574.0 million in 2025.
- Per Business Quant database, its latest 3 readings for Cash & Current Investments were $574.0 million in Q4 2025, $672.0 million in Q3 2025, and $599.0 million in Q2 2025.